AV Fistula Clinical Trial
Official title:
Ellipsys Vascular Access System Post Market Surveillance (PS) Study PS200001 Reference DEN170004
The proposed clinical study is a prospective, non-randomized, multi-center, single-arm, observational, post-market surveillance (PS) study of the Ellipsys Vascular Access System in subjects eligible for arteriovenous (AV) fistula.
The primary objective of this post-market surveillance study is to support the short-term safety of the device and procedure and further assess long-term safety and effectiveness in subjects treated by newly trained providers of the Ellipsys Vascular Access System in the creation of a native AV fistula via percutaneous access in subjects who are on hemodialysis and are medically indicated for the creation of an upper limb anastomosis. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05462223 -
Alucent Vessel Restoration System for AVF
|
N/A | |
| Completed |
NCT02363972 -
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
|
N/A | |
| Terminated |
NCT04626427 -
The WavelinQ™ Arterio-Venous Endovascular Fistula: A Global, Post-Market Investigation
|
N/A | |
| Completed |
NCT01471041 -
Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)Fistulae
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT05569109 -
av Fistula Patency Loss as a Cause of Fistula Failure and Hyperphosphatemia
|
||
| Completed |
NCT02475837 -
Vorapaxar Study for Maturation of AV Fistulae for Hemodialysis Access
|
Phase 2 | |
| Active, not recruiting |
NCT04327609 -
SAVE Trial - Use of the Selution Sirolimus Eluting Balloon for Dysfunctional AV accEss Treatment Indications
|
N/A |